Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 31, 2021
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
[ Wed, Mar 31st 2021
] - WOPRAI
Tue, March 30, 2021
[ Tue, Mar 30th 2021
] - WOPRAI
[ Tue, Mar 30th 2021
] - WOPRAI
Mani Foroohar Reiterated (WVE) at Hold with Decreased Target to $7 on, Mar 30th, 2021
Mani Foroohar of SVB Leerink, Reiterated "Wave Life Sciences Ltd." (WVE) at Hold with Decreased Target from $10 to $7 on, Mar 30th, 2021.
Mani has made no other calls on WVE in the last 4 months.
There is 1 other peer that has a rating on WVE. Out of the 1 peers that are also analyzing WVE, 0 agree with Mani's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mani
- Debjit Chattopadhyay of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $20 on, Tuesday, December 15th, 2020
